维普期刊资源整合服务平台（V6.5）

99篇 您的检索式：作者名="Wielenga"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	European vs 2015-World Health Organization clinical molecular and pathological classification of myeloproliferative neoplasms显示文摘The BCR/ABL fusion gene or the Ph^1-chromosome in the t(9;22)(q34;q11)exerts a high tyrokinase acticity,which is the cause of chronic myeloid leukemia(CML).The1990 Hannover Bone Marrow Classification separated CML from the myeloproliferative disorders essential thrombocythemia(ET),polycythemia vera(PV)and chronic megakaryocytic granulocytic myeloproliferation(CMGM).The 2006-2008 European Clinical Molecular and Pathological(ECMP)criteria discovered 3variants of thrombocythemia:ET with features of PV(prodromal PV),'true'ET and ET associated with CMGM.The 2008 World Health Organization(WHO)-ECMP and 2014 WHO-CMP classifications defined three phenotypes of JAK2^(V617F)mutated ET:normocellular ET(WHO-ET),hypercelluar ET due to increased erythropoiesis(prodromal PV)and ET with hypercellular megakaryocytic-granulocytic myeloproliferation.The JAK2^(V617F)mutation load in heterozygous WHO-ET is low and associated with normal life expectance.The hetero/homozygous JAK2^(V617F)mutation load in PV and myelofibrosis is related to myeloproliferative neoplasm(MPN)disease burden in terms of symptomaticsplenomegaly,constitutional symptoms,bone marrow hypercellularity and myelofibrosis.JAK2 exon 12mutated MPN presents as idiopathic eryhrocythemia and early stage PV.According to 2014 WHO-CMP criteria JAK2 wild type MPL^(515)mutated ET is the second distinct thrombocythemia featured by clustered giant megakaryocytes with hyperlobulated stag-horn-like nuclei,in a normocellular bone marrow consistent with the diagnosis of'true'ET.JAK2/MPL wild type,calreticulin mutated hypercellular ET appears to be the third distinct thrombocythemia characterized by clustered larged immature dysmorphic megakaryocytes and bulky(bulbous)hyperchromatic nuclei consistent with CMGM or primary megakaryocytic granulocytic myeloproliferation.	Jan Jacques Michiels Fransje Valster Jenne Wielenga Katrien Schelfout Hendrik De Raeve	2015	World Journal of Hematology2015，4，3：	3
2	Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression显示文摘	Wielenga VJ Heider KH Offerhaus GJ	1993	Cancer Res1993，53，20：	1
3	Expression of CD44 variant poteins in humen colorectal cancer related to tumor progression 显示文摘	Heider KH Offerhaus GJA	1993	Cancer Res1993，53，22：	1
4	Cryopreservation of ovarian tissue for fertility preserva-tion:no evidence of malignant cell contamination in ovariantissue from patients with breast cancer显示文摘	Rosendahl M Timmermans Wielenga V Nedergaard L		0，，6：	1
5	Expression of mutant p53 protein and CD44 variant proteins in colorectal tumorigenesis显示文摘	Mulder JW Wielenga VJ Polak MM	1995	Cut1995，36，5：	1
6	Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met显示文摘	VOORT R TAHER T I WIELENGA V M	1999	J Biol Chem1999，274，10：	1
7	Severe infective endocarditis due to Neisseria sic- ca: case report and review of literature显示文摘	JEURISSEN A STROY J P WIELENGA R P	2006	Acta Clin Belg2006，61，：	1
8	Expression of mutant p53 protein and CD44 variant proteins in colorectal tumorgenesis显示文摘	Mulder JWR Wielenga VTM Polak MM	1995	Gut1995，36，1：	1
9	Experssion of CD44 variant proteins in human colorectal cancer is related to tumor progression显示文摘	Wielenga V J Heider KH Offerhaus G J	1993	Caner Res1993，53，20：	1
10	Expression of c-Met and heparan-sulfate proteoglycan forms of CD44 in colorectal cancer显示文摘	ROBBERT VAN DER VOORT TAHER E I TAHER	2000	American Journal of Pathology2000，157，：	1
11	CD44 expression predicts disease outcorhe in localized large B cell lymphoma显示文摘	Drillenburg P Wielenga VJ Kramer MH	1999	Leukemia1999，13，9：	1
12	Safety and effects of physical training in chronic heart failure, results of the chronic heart failure and graded exercise study显示文摘	Wielenga RP Huissveld IA Bol E et ai	1999	Eur Heart J1999，20，12：	1
13	Heparan sulfate- modified CD44 promotes hepatocyte growth factor/scatter factor- induced signal transduction through the receptor tyrosion kinasc c-Met 显示文摘	Van der Voort R Taher TE Wielenga VJ	1999	J Biol Chem1999，274，10：	1
14	Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression显示文摘	Heider KH Offerhaus GJ	1993	Cancer Res1993，53，20：	1
15	Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression显示文摘	WIELENGA V J HEIDER K H OFFERHAUS G J	1993	Cancer Res1993，53，20：	1
16	Experssion of CD44variant proteins in human colorectal cancer is related to tumor pro-gression显示文摘	Wielenga VJ Heider KH Offerhaus GJ	1993	Caner Res1993，53，20：	1
17	CD44 expression predicts disease outcome in localized large B cell lymphoma显示文摘	Drillenburg P Wielenga VJ Kramer MH	1999	Leukemia1999，13，9：	1
18	Expression of CD44 varient proteins in human colorected cancer is related to tumour progression显示文摘	Heider KH Offerhaus JA	1993	Cancer Res1993，53，20：	1
19	Expression of CD44 variant proteins in human eolorectal cancer is related to tumor progression显示文摘	Heider KH Offerhaus JA	1993	Cancer Res1993，53，：	1
20	Develop-rnent and growth in very preterm infants in relation to NIDCAP in a Dutch NICUtwo years of follow-up显示文摘	Wielenga JM Smit BJ Merkus MP	2009	Acta Paediatr2009，98，2：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示